Premium
Theriva Biologics Inc (TOVX)
AMEX
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, ... Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.06 | -4.3795620438 | 1.37 | 1.46 | 1.23 | 195761 | 1.30574834 | CS |
| 4 | -0.86 | -39.6313364055 | 2.17 | 2.19 | 1.22 | 166370 | 1.43064125 | CS |
| 12 | -2.47 | -65.3439153439 | 3.78 | 4.29 | 1.22 | 2932866 | 1.88375168 | CS |
| 26 | -5.455 | -80.6356245381 | 6.765 | 7.3725 | 1.22 | 2000788 | 2.84497425 | CS |
| 52 | -13.6375 | -91.2359926409 | 14.9475 | 17.1125 | 1.22 | 1167299 | 3.71525205 | CS |
| 156 | -18.69 | -93.45 | 20 | 31.5 | 1.22 | 655397 | 6.68250295 | CS |
| 260 | -18.69 | -93.45 | 20 | 31.5 | 1.22 | 655397 | 6.68250295 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| MSTZT Rex 2X Inverse MSTR Daily Target ETF | US$ 0,9556 (-4,11%) | 614,58M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 29,61 (1,68%) | 49,15M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,165 (3,77%) | 39,96M |
| SPYSPDR S&P 500 | US$ 607,81 (0,19%) | 30,8M |
| TZADirexion Daily Small Cap Bear 3X Share New | US$ 10,485 (-1,08%) | 30,58M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
